FDA revises action on compounded ibuprofen, citing oral version shortage
The FDA put out guidance Thursday expanding supply of a specific form of ibuprofen, one of the major active ingredients in over-the-counter pain relief medicine such as Advil.
In its newest revised guidance, the federal regulatory agency is now giving the green light to outsourcing facilities to provide compounded, orally suspended forms of ibuprofen to state-licensed pharmacies that can be given to patients at home, provided that a patient has a valid and patient-specific prescription.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.